During the last session, GeneDx Holdings Corp (NASDAQ:WGS)’s traded shares were 0.76 million, with the beta value of the company hitting 2.36. At the end of the trading day, the stock’s price was $60.00, reflecting an intraday gain of 9.09% or $5.0. The 52-week high for the WGS share is $57.53, that puts it up 4.12 from that peak though still a striking 98.07% gain since the share price plummeted to a 52-week low of $1.16. The company’s market capitalization is $1.62B, and the average intraday trading volume over the past 10 days was 0.66 million shares, and the average trade volume was 465.70K shares over the past three months.
GeneDx Holdings Corp (WGS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. WGS has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.21.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GeneDx Holdings Corp (NASDAQ:WGS) trade information
GeneDx Holdings Corp (WGS) registered a 9.09% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 9.09% in intraday trading to $60.00, hitting a weekly high. The stock’s 5-day price performance is 20.43%, and it has moved by 57.19% in 30 days. Based on these gigs, the overall price performance for the year is 1649.27%. The short interest in GeneDx Holdings Corp (NASDAQ:WGS) is 2.21 million shares and it means that shorts have 5.37 day(s) to cover.
The consensus price target of analysts on Wall Street is $38.5, which implies a decrease of -55.84% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $21 and $45 respectively. As a result, WGS is trading at a premium of 25.0% off the target high and 65.0% off the low.
GeneDx Holdings Corp (WGS) estimates and forecasts
Statistics show that GeneDx Holdings Corp has outperformed its competitors in share price, compared to the industry in which it operates. GeneDx Holdings Corp (WGS) shares have gone up 523.70% during the last six months, with a year-to-date growth rate more than the industry average at 85.55% against 7.30. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 74.40% this quarter and then jump 76.80% in the quarter after that. In the rating firms’ projections, revenue will increase 30.00% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 64.99M as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to 67.13M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 53.3M and 57.42M respectively. In this case, analysts expect current quarter sales to grow by 21.90% and then jump by 16.90% in the coming quarter.
While earnings are projected to return 76.59% in 2024.
WGS Dividends
GeneDx Holdings Corp is due to release its next quarterly earnings on 2024-Oct-29. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
GeneDx Holdings Corp insiders own 25.42% of total outstanding shares while institutional holders control 62.21%, with the float percentage being 83.41%.
